指南与共识针灸推拿中医内科中医康复

针灸治疗癌痛的循证临床实践指南

Acupuncture for cancer pain: an evidence-based clinical practice guideline.
指南 / 共识 · Chin Med · 2022-01-05

本指南旨在为针灸治疗中重度癌痛提供循证推荐,由国际多学科专家组基于2020年JAMA Oncology的系统评价,采用GRADE方法并经德尔菲共识制定。指南提出三条推荐:强推荐针灸而非不治疗以缓解中重度癌痛;弱推荐在镇痛药基础上联用针灸/指压以减轻疼痛、减少阿片剂量及副作用;强推荐针灸用于乳腺癌患者芳香化酶抑制剂相关关节痛。证据样本量小限制了推荐强度。

要点

  • 强推荐针灸而非不治疗用于缓解中重度癌痛。
  • 弱推荐镇痛药联用针灸/指压以减痛、减阿片剂量及副作用。
  • 强推荐针灸用于乳腺癌患者芳香化酶抑制剂相关关节痛。

核心结论

  • 指南为针灸治疗癌痛提供三条推荐,证据样本量小限制推荐强度并提示需更多研究。

研究设计与样本

  • 由国际多学科专家组(含13名西医肿瘤学家、中医/针灸临床从业者及2名患者代表)通过德尔菲共识制定,采用GRADE方法评级证据确定性与推荐强度。

主要发现

  • 强推荐针灸而非不治疗以缓解中重度癌痛患者的疼痛。
  • 弱推荐对使用镇痛药的中重度癌痛患者联用针灸/指压以减轻疼痛强度、减少阿片剂量及缓解阿片相关副作用。
  • 强推荐针灸用于乳腺癌患者以缓解芳香化酶抑制剂诱导的关节痛。

关键数值与推荐

  • 推荐基于2020年JAMA Oncology发表的系统评价触发,并检索患者偏好与价值观等证据。
  • 采用GRADE方法评级证据确定性与推荐强度,制定时充分考虑证据确定性、患者偏好与价值观、资源等因素。

临床怎么用

  • 对中重度癌痛患者可推荐针灸作为缓解疼痛的治疗选择。
  • 对使用镇痛药的中重度癌痛患者可考虑联用针灸/指压以辅助减痛、减少阿片剂量及副作用。
  • 对乳腺癌患者芳香化酶抑制剂相关关节痛可推荐针灸治疗。

局限性

  • 证据样本量小,限制了推荐强度。
  • 需额外研究以加强证据基础。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to develop an evidence-based clinical practice guideline of acupuncture in the treatment of patients with moderate and severe cancer pain. METHODS: The development of this guideline was triggered by a systematic review published in JAMA Oncology in 2020. We searched databases and websites for evidence on patient preferences and values, and other resources of using acupuncture for treatment of cancer pain. Recommendations were developed through a Delphi consensus of an international multidisciplinary panel including 13 western medicine oncologists, Chinese medicine/acupuncture clinical practitioners, and two patient representatives. The certainty of evidence, patient preferences and values, resources, and other factors were fully considered in formulating the recommendations. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach was employed to rate the certainty of evidence and the strength of recommendations. RESULTS: The guideline proposed three recommendations: (1) a strong recommendation for the treatment of acupuncture rather than no treatment to relieve pain in patients with moderate to severe cancer pain; (2) a weak recommendation for the combination treatments with acupuncture/acupressure to reduce pain intensity, decrease the opioid dose, and alleviate opioid-related side effects in moderate to severe cancer pain patients who are using analgesics; and (3) a strong recommendation for acupuncture in breast cancer patients to relieve their aromatase inhibitor-induced arthralgia. CONCLUSION: This proposed guideline provides recommendations for the management of patients with cancer pain. The small sample sizes of evidence limit the strength of the recommendations and highlights the need for additional research.

来源:Chin Med,查看原文。版权归原作者所有。

引用

  1. Ge L, Wang Q, He Y, et al. Acupuncture for cancer pain: an evidence-based clinical practice guideline. Chin Med. 2022. PMID: 34983587. doi:10.1186/s13020-021-00558-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。